Regenerative Medicines Market to Report Impressive Growth, Revenue to Surge to US$26.30 Billion by 2024
Global regenerative medicines market expected to generate revenue of around USD 26.30 billion by the end of 2024, growing at a CAGR of around 18.59% between 2017 and 2024. Regenerative medicines include the process of regenerating human cells, organs, and tissues to restore its normal function.
View full press release